Patient and Physician Preferences for Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer Treatments
The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting
⁃ Patients
• Aged ≥18 years at the time of enrollment in the study
• Resident of the US, Germany, or Japan
• Able to read, speak, and understand English, German or Japanese
• Diagnosed with resectable phase II to IIIB non-small cell lung cancer (NSCLC)
⁃ Physicians
• Resident of the US, Germany, or Japan
• Lung cancer-treating physician specialized in one of the following medical areas: oncology, pneumonology, thoracic surgery, or radiology
• Treated at least three new patients with resectable NSCLC in the past year